Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

DR REDDYS LA

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 63
  • 0 comments

FDA approve IBUPROFEN

Comment Full text

OXFORD PHARMS

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 59
  • 0 comments

FDA approve ETODOLAC

Comment Full text

GALT PHARMS

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 58
  • 0 comments

FDA approve ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE

Comment Full text

L PERRIGO CO

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 52
  • 0 comments

FDA approve IBUPROFEN

Comment Full text

SANDOZ

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 55
  • 0 comments

FDA approve ETODOLAC

Comment Full text

TARO

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 42
  • 0 comments

FDA approve ETODOLAC

Comment Full text

MICRO LABS

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 44
  • 0 comments

FDA approve DICLOFENAC SODIUM

Comment Full text

CHARTWELL MOLECULES

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 61
  • 0 comments

FDA approve ETODOLAC

Comment Full text

APOTEX INC

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 52
  • 0 comments

FDA approve ETODOLAC

Comment Full text

CHARTWELL RX

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 54
  • 0 comments

FDA approve NABUMETONE

Comment Full text
  • Previous
  • 298
  • 299
  • 300
  • 301
  • 302
  • Next

Search

News categories

  • Technical Exchange News(14634)
  • Event(6229)
  • SEC News(388519)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(236998)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin